Sort
40,608 grants matching “prostate cancer”
Community Outreach and Engagement
$512,726Alyce Sophia Adams · Stanford University · P30 · FY2024 · CA
KINASE INHIBITORS PRESENT EXCITING THERAPIES FOR CANCER INCLUDING PROSTATE CANCER.
$512,600University Of Washington · · FY2017 · Department of the Army
Synthetic Lethal Targeting of SETD2 in Renal Cell Carcinoma
$512,562Keith D Robertson · Mayo Clinic Rochester · R01 · FY2024 · CA
The Detection, Isolation and Characterization of Disseminated Tumor Cells
$512,493Robert Vessella · University Of Washington · P01 · FY2013 · CA
Mitochondrial Hsp90 chaperones and prostate cancer therapy
$512,491Dario C. Altieri · Wistar Institute · P01 · FY2012 · CA
Image-guided radiation-induced permeability (IGRIP) for IGDD
$512,434Stephen J. Kron · University Of Chicago · R01 · FY2015 · CA
Integrated Biochip Sensors for Detection of Cancer
$512,381Rashid Bashir · University Of Illinois At Urbana-Champaign · R01 · FY2008 · CA
EPITHELIAL CELL PROFILING IN DEVELOPING EXCURRENT DUCT
$512,318Massachusetts General Hospital · R01 · FY2001 · HD
ROLE OF COREGULATORS IN STEROID HORMONE-REGULATED TRANSCRIPTION
$512,285Michael R Stallcup · University Of Southern California · R01 · FY2010 · DK
Homologous recombination repair capacity in peripheral blood lymphocytes as a breast cancer risk factor
$512,284Hua Zhao · Virginia Commonwealth University · U01 · FY2022 · CA
GI Tract Dysbiosis and Breast Cancer
$512,279Susan E. Erdman · Massachusetts Institute Of Technology · U01 · FY2015 · CA
Harnessing the CRL4 ubiquitin ligase for antagonizing colorectal carcinogenesis
$512,266Pengbo Zhou · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · CA
Multiplexed Nanosensing for DNA and Proteins
$512,260Richard James Cote · University Of Miami School Of Medicine · R01 · FY2008 · EB
Diffusion Histology Imaging: A Clinical Tool to Non-Invasively Diagnose and Manage Prostate Cancer
$512,247Joseph Edward Ippolito · Washington University · R01 · FY2025 · CA
Examining the Relationship between Residential History at Midlife and Prostate Cancer Outcomes
$512,007Charnita M Zeigler-Johnson · Research Inst Of Fox Chase Can Ctr · R01 · FY2025 · MD
Drug Discovery for Fatty Acid Synthase in Oncology
$511,937Jeffrey W Smith · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2014 · CA
SECETORY PHOSPHOLOPASE A2-RESPONSIVE LIPOSOMAL DELIVERY OF IPA-3FOR PROSTATE CANCER THERAPY
$511,760University Of Georgia Research Foundation, Inc. · · FY2016 · Department of the Army
Reactive Stroma and Tumor Associated Macrophages in Prostate Cancer Progression
$511,752Kenneth J. Pienta · Johns Hopkins University · U01 · FY2014 · CA
Leveraging cross-cancer shared heritability to better understand the genetic architecture of cancer
$511,750Sara Lindstroem · University Of Washington · R01 · FY2022 · CA
Project 2 - Investigating Clinical and Biological Implications of a Novel Hypermethylated Subtype of Metastatic Castration Resistant Prostate Cancer (mCRPC)
$511,680Eric J Small · University Of California, San Francisco · P50 · FY2024 · CA
Project 1-Combination Immunotherapy with Radioligned Therapy for Metastatic Prostate Cancer
$511,680Lawrence Fong · University Of California, San Francisco · P50 · FY2024 · CA
Project 3 - Deciphering the Role of the Translational Oncogenic Program in Prostate Cance
$511,680Davide Ruggero · University Of California, San Francisco · P50 · FY2024 · CA
Molecular Epidemiology of Fatal Prostate Cancer
$511,516Kaiser Foundation Research Institute · R01 · FY2003 · CA
Improving prostate cancer screening by integration of SNPs with blood biomarkers
$511,511Robert J. Klein · Sloan-Kettering Inst Can Research · R01 · FY2013 · CA
Validating and Extending the PROMIS Sexual Function Measure for Clinical Research
$511,478Kevin P Weinfurt · Duke University · U01 · FY2009 · AR